@leahlabs.com
LEAH Labs is a biotechnology company building living therapies for pets and their people.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
LEAH Labs is a pioneering biotechnology company that is dedicated to developing living therapies for pets and their owners. At LEAH Labs, we are currently enrolling pets with B cell lymphoma in a fully funded pilot efficacy trial. Our goal is to bring breakthrough CAR-T cell therapy, an FDA-approved treatment for humans with cancer, to our furry family members facing similar cancers.
CAR-T cell therapy involves genetically reprogramming T immune cells to recognize and destroy cancer cells. Our team consists of highly skilled individuals, including our founder and CEO, Wes Wierson, PhD, and our VP of Cell Biology, Alex Abel, PhD. We also have a dedicated research technician, Alyssa Juergens, working to advance our innovative treatments.
Through our research on pets, we are uncovering new mechanisms that can potentially aid in the development of therapies for humans as well. Our cutting-edge cell programming technology, pioneered by our founders, helps immune cells seek and destroy cancer cells in pets and humans alike. LEAH Labs is supported by a strong network of investors and grants, including Y Combinator, AgStartup Engine, FIN Capital, and various angel investors.
We have received grants from NSF SBIR, NIH SBIR, LaunchMN, and Regenerative Medicine Minnesota. Join us in our mission to revolutionize cancer treatment for pets and humans. Contact us today to learn more about our trials and how they can benefit your furry companion
Company Type
Privately Held
Company Size
2-10
Year Founded
2018
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories